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Abstract
Background: The generic questionnaire WHO-5 Well-being Index (WHO-5), which measures the construct of mental
well-being has been widely used in several populations across countries. The questionnaire has demonstrated sufficient
psychometric properties; however, the test- retest reliability of the WHO-5 scale has yet to be determined. The aim of
this study was to evaluate the test-retest reliability and measurement error of the Danish WHO-5 Well-being Index for
outpatients with epilepsy. A further aim was to evaluate whether the method of administration (web, paper, or a
mixture of the two modalities) influenced the results.
Methods: Epilepsy outpatients aged ≥15 years from three outpatient clinics in Central Denmark Region were included
from August 2016 to April 2017. The participants were randomly divided into four test-retest groups: web-web,
paper-paper, web-paper, and paper-web. Test-retest reliability was assessed by intraclass correlation coefficients
(ICC) and measurement error by calculating minimal detectable change (MDC) on the basis of the standard error
of the measurement.
Results: A total of 554 patients completed the questionnaire at two time points. The median duration between
test-retest was 22 days. The pooled test-retest reliability estimate was ICC 0.81 (95% CI 0.78; 0.84). The estimated
MDC was 23.60 points (95% CI 22.27; 25.10). These estimates showed little variation across administration methods.
Conclusions: WHO-5 showed acceptable test-retest reliability in a Danish epilepsy outpatient population across
different method of administration; however, the relatively large measurement error should be taken into account
when evaluating changes in WHO-5 scores over time. Further research should be done to explore these findings.
Keywords: Patient reported outcome measures, Validation studies as topic, Reproducibility of results
Introduction
Several considerations are important when selecting
patient-reported outcome (PRO) measures for use in
clinical practice. A PRO measure should be relevant to
patients and clinicians and possess an adequate level of
psychometric evidence for the instrument in the target
population [1]. In Central Denmark Region, PRO mea-
sures have been used as the basis for follow-up in three
epilepsy outpatient clinics since 2012 [2, 3]. Patients
complete a web or paper-based questionnaire at home
instead of having pre-scheduled appointments. Clinical
resources could then be directed towards patients with
actual need, and clinicians could use patients’
self-reported information to identify otherwise un-
detected problems. As depression is common in patients
with epilepsy [4], valid and reliable measurement tools
are necessary to identify relevant symptoms. For this
purpose, the WHO-5 Well-being Index (WHO-5) was
selected and has been used since 2012 for outpatients
with epilepsy in Central Denmark Region.
WHO-5 is a generic unidimensional questionnaire
reflecting the construct mental well-being during the last
2 weeks [5]. The scale was developed in 1998 and has
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been widely used [6]. WHO-5 includes five positive word-
ing statements rated on a 6-point ordinal scale ranging
from 5 “all of the time” to 0 “at no time”. Raw scores,
which range from 0 to 25, are multiplied by 4 to obtain a
percentage score ranging from 0 (worst) to 100 (best). A
percentage score below 50 indicates poor mental
well-being and a risk of depression. The WHO-5 has dem-
onstrated sufficient psychometric properties in terms of
construct validity, predictive validity, and internal
consistency reliability in several patient populations in-
cluding epilepsy [6–14]; however, the test- retest reliability
of the WHO-5 scale has yet to be determined. Further-
more, few studies have explored the impact on consistency
of using different methods of administration [15, 16].
The study aim was to evaluate the test-retest reliability
and measurement error of the Danish WHO-5
Well-being Index for outpatients with epilepsy. A further
aim was to evaluate whether the method of administra-
tion (web, paper, or a mixture of the two modalities) in-
fluenced the results.
Methods
Study population and setting
Patients with epilepsy aged ≥15 years from three out-
patient clinics in Central Denmark Region were included
from August 2016 to April 2017. The patients completed
the questionnaire at two time points. First, they com-
pleted a questionnaire from the outpatient clinic based
on their preferred web or paper administration method
(test 1). Subsequently, approximately 2 weeks later, a let-
ter was sent to the patients asking them to complete the
same questionnaire again (test 2). The patients were ran-
domly divided into four test-retest groups based on the
method of administration at test 1 and test 2: web-web,
paper-paper, web-paper, and paper-web. Three re-
minders were sent in test 1, but no reminders were sent
to non-responders in test 2. The WHO-5 Well-being
Index was included in the questionnaire in test 1. In
addition, the questionnaire included other items, regard-
ing, for example, seizures, symptoms, and general health.
The general health construct was measured by using
two items from the Danish version of the Short Form 36
Health Survey [17, 18]. A long interval between test ad-
ministrations increases the risk of change in patients’
health status in a test-retest study, whereas a short inter-
val increases the risk of recall bias [19]. The question-
naire in test 1 was sent to the patients as part of routine
outpatient follow-up. Patients’ mental health was as-
sumed to be stable during the time period from test 1 to
test 2, since the health status of epilepsy patients is not
likely to change over a period of 2 weeks. The patients
were not asked in test 2 whether their mental health had
changed within the time period.
Data analyses
Descriptive statistics were generated for patient charac-
teristics and for each item to determine the extent of
missing values and floor- or ceiling effects, which were
considered present if more than 15% had a score at the
lower or upper end of the scale [19]. Cronbach’s alpha
was used to assess internal consistency. The 95% confi-
dence interval (CI) of the Cronbach’s alpha values was
estimated by using the bootstrap method (1000 replica-
tions). The time interval between test 1 and 2 was cal-
culated as the difference in number of days from the
dates of responses. Test-retest reliability of the scale
was assessed by intraclass correlation coefficients (ICC)
agreement model 2.1 [20], with 95% CI, and for single
items, kappa with squared weights and 95% CI was
used. An ICC value of 0.70 is considered acceptable for
group level analysis, but when evaluating individual pa-
tients, an ICC of 0.90 is recommended [19]. The kappa
values were interpreted as following: < 0.2 (slight),
0.21–0.4 (fair), 0.41–0.6 (moderate), 0.61–0.8 (substan-
tial), and 0.81–1.0 (almost perfect) [21]. Measurement
error was assessed with differences between test 1 and
2 plotted against the means of the two measurements
by Bland–Altman plots with 95% CI and 95% limits of
agreement (LOA). LOA equals the mean change in
scores between test 1 and 2 (mean change ±1.96 x
Table 1 Patient characteristics at time of test 1 among outpatients
with epilepsy, N= 554
Gender, n (%) Male 286 (52)
Age, y, median (IQR) 57.3 (25.1)
Outpatient clinic, n (%)
Aarhus 409 (74)
Holstebro 115 (21)
Viborg 30 (5)
General healtha, n (%)
Excellent 67 (12.1)
Very good 191 (34.5)
Good 209 (37.7)
Fair 68 (12.3)
Poor 19 (3.4)
WHO-5 score in test 1
Median (IQR) 76 (24)
Mean (SD) 70.6 (19.5)
Missing, n (%) 5 (0.9)
WHO-5 score in test 2
Median (IQR) 76 (24)
Mean (SD) 70.5 (19.2)
Missing, n (%) 9 (1.6)
aItem GH-1 from Short Form 36 Health Survey [17]
Abbreviations IQR inter quartile range, SD Standard deviation
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standard deviation of the changes) and gives an indica-
tion of how much two scores can vary in stable pa-
tients. LOA are expressed in the units of measurement
instrument and give a direct indication of the size of
the measurement error [19]. The measurement errors
reflect the within intraindividual variation and were es-
timated as the standard error of the measurement
(SEM) [22]. SEM equals the square root of the error
variance. The interpretation of a SEM estimate is not
straight forward; therefore the SEM was converted into
the minimally detectable change (MDC). MDC95 equals
1.96 ± √2 x SEM and indicates the smallest
within-person change that can be interpreted as a “real”
individual change above the measurement error
[22]. Thus, a change in scores within the LOA or
smaller than MDC95can be attributed to measurement
error [19]. Patients with missing item values were ex-
cluded from the analyses. Two sensitivity analyses were
performed to investigate whether the length of the time
interval between test 1 and test 2 affected our results.
In the first analysis, patients were excluded if the time
period between test 1 and test 2 was above 30 days, and
in the second analysis all patients with a time interval
above 14 days were excluded. STATA 15 software (Stata
Corp, College Station) were used for all statistical
analyses.
Results
Patient and item characteristics
A total of 554/1640 (34%) patients responded to the
questionnaire twice. The median age was 57.3 years
(Table 1). The response-rates in the four test-retest
groups ranged from 48% (web-paper and paper-paper)
to 34% (web-web) to 9% (paper-web). Non-responders
were more likely younger, paper-responders, and had
lower self-reported general health in test 1 (data not
shown). The median response time between test-retest
was 22 days (inter quartile range 10 days). A total of 14
patients had missing values for WHO-5 in test 1 or 2
and were excluded from the analyses. Percentages of
missing values ranged from 0.2 to 1.1%, and there was a
tendency towards ceiling effects in all items (Table 2).
Cronbach’s alpha was 0.89 (95% CI 0.87; 0.90) in test 1
and 0.89 (95% CI 0.87; 0.91) in test 2.
Test-retest reliability and measurement error of WHO-5
Kappa values for the five single items were substantial
(Table 2) [21]. The ICC of the pooled WHO-5 score was
0.81 (95% CI 0.78; 0.84) (Table 3). Differences between
test 1 and test 2 plotted against the mean of the two
tests with upper and lower LOAs are shown in Fig. 1.
The estimated SEM was 8.51 points (95% CI 8.03; 9.05),
Table 2 Item level distribution and weighted kappa of the WHO-5 Well-being Index (N = 554)
Item Distribution (%) of the response optionsa Test-retest
Weighted
kappa
Item content Missing 0 1 2 3 4 5
1 I have felt cheerful and in good spirits Test 1 0.2 0.5 5.2 5.6 12.3 61.6 14.6 0.70 (0.64; 0.76)
Test 2 0.7 0.5 3.4 6.3 14.1 61.4 13.5
2 I have felt calm and relaxed Test 1 0.5 1.4 4.9 6.0 15.2 52.0 20.0 0.67 (0.59; 0.74)
Test 2 0.5 1.3 2.7 7.9 13.4 56.9 17.3
3 I have felt active and vigorous Test 1 0.2 3.1 8.5 13.0 21.7 37.7 15.9 0.70 (0.65; 0.76)
Test 2 0.5 2.9 9.0 13.5 19.7 41.9 12.5
4 I woke up feeling fresh and rested Test 1 0.2 4.7 10.6 10.5 18.8 40.4 14.8 0.72 (0.66; 0.77)
Test 2 1.1 5.4 9.0 11.4 17.0 41.9 14.3
5 My daily life has been filled with things that interest me Test 1 0.5 0.9 5.4 7.0 16.6 51.3 18.2 0.68 (0.62; 0.74)
Test 2 1.1 0.7 7.6 6.5 15.0 51.3 17.9
a0 = At no time, 1 = Some of the time, 2 = Less than half of the time, 3 = More than half of the time, 4 = Most of the time, 5 = All of the time
Table 3 Test-retest reliability and measurement error for the WHO-5 Well-being Index between test 1 and test 2
WHO-5 N Mean, (95% CI) Test 1 Mean (95% CI) Test 2 Difference (95% CI) SEM (95% CI) ICC (95% CI) MDC95 (95% CI)
Pooled 540 70.58 (68.94; 72.21) 70.40 (68.78; 72.02) 0.18 (−0.84; 1.20) 8.51 (8.03; 9.05) 0.81 (0.78; 0.84) 23.60 (22.27; 25.10)
Web-web 164 69.83 (66.73; 72.93) 70.10 (67.01; 73.18) −0.27 (−2.02; 1.49) 8.05 (7.26; 9.03) 0.84 (0.80; 0.89) 22.31 (20.13; 25.03)
Paper-paper 107 70.65 (66.41; 74.90) 70.69 (66.87; 74.51) −0.04 (− 2.56; 2.49) 9.31 (8.21; 10.76) 0.81 (0.74; 0.87) 25.81 (22.76; 29.82)
Web-paper 233 71.10 (68.85; 73.33) 70.73 (68.37; 73.09) 0.36 (−1.17; 1.89) 8.36 (7.66; 9.20) 0.78 (0.73; 0.83) 23.18 (21.24; 25.49)
Paper-web 36 70.44 (63.63; 77.26) 68.78 (62.05; 75.50) 1.67 (−2.79; 6.12) 9.30 (7.55; 12.14) 0.78 (0.66; 0.91) 25.79 (20.92; 33.64)
Abbreviations: WHO-5 WHO-5 Well-being Index, N Number, CI Confidence Interval, SEM Standard error of the measurement, ICC Intra class correlation coefficient,
MDC Minimal detectable change
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which resulted in a MDC95 of 23.60 points (95% CI
22.27; 25.10). The analysis was repeated in the four
test-retest groups (Table 3 and Fig. 2). Administration
methods did not noticeably alter the estimates. The
overall results did not change, when the analyses were
repeated with restricted intervals between test 1 and 2.
Discussion
Test-retest reliability of the Danish WHO-5 Well-being
Index was found to be acceptable in an epilepsy out-
patient population, but a relatively large measurement
error was observed. The estimated MDC95 was 23.60
points, indicating that changes in the WHO-5
instrument must be substantial to ensure that a ‘real’
change is not due to measurement error. Methods of ad-
ministration did not markedly influence the results.
This study follows the COSMIN framework [23, 24] and
supplements earlier established psychometric properties
of the WHO-5. Since we were unable to identify other
test-retest studies of the scale, we believe this is the first
study to determine the test-retest reliability of the
WHO-5. Several studies have explored another aspect of
reliability: internal consistency [8–14]. The Cronbach’s
alpha of the WHO-5 in these studies ranged from 0.82 to
0.95, which is consistent with the findings in this study.
However, this aspect determines the correlation between
items within a scale and not the degree of agreement for
repeated measurements over time [22, 24]. The unidimen-
sionality of the WHO-5 scale has been confirmed by using
Rasch item response theory analyses in both a younger
and elderly population [14, 25].
Test-retest reliability should be assessed in a stable
population with an appropriate time interval between
measurements [22]. We assumed that the epilepsy out-
patient population was stable and allowed a longer time
interval. Sensitivity analyses were used to assess poten-
tial change in health status; however, excluding partici-
pants with longer intervals between test 1 and 2 did not
substantially alter the estimates. Still, we cannot rule out
that a change in patients’ health status had occurred and
that this might have affected the ICC and measurement
error estimates of the WHO-5 scale, as we did not col-
lect information on the change in patients’ mental health
status from test 1 to test 2.
Fig. 1 Differences in the WHO-5 Well-being Index score between
test 1 and test 2 plotted against the mean, N = 540
Fig. 2 Differences in the WHO-5 Well-being Index score between test 1 and test 2 plotted against the mean in the four test-retest groups: web-web
(n = 164), paper-paper (n = 107), web-paper (n = 233), and paper-web (n = 36)
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The WHO-5 scale ranges from 0 to 100, and an MDC
of 23.6 points observed in this study may indicate that
longitudinal differences of at least 24 points are needed
to detect a “true” within-person change. The relatively
large measurement error observed in this study may be
taken into consideration by researchers planning future
clinical trials and clinicians who use the scale on the in-
dividual level in clinical practice to evaluate change over
time. Furthermore, the tendency towards ceiling effect
may produce difficulties in measuring longitudinal
changes. Web, paper, or a mixture of the two modalities
showed nearly the same test-retest reliability, which is
consistent with other test-retest studies [15, 16].
One important limitation of this study is the possibility
of selection bias. A very low response rate was observed
especially in the paper-web group (9%). This may be due
to the pragmatic design, which allowed patients to
choose administration method for their response to test
1. In the Danish general population, a mean WHO-5
score of 70 points has been reported [26, 27]. This is
comparable with the result in this study; however, the
responders tended to be a healthier group of patients
compared to non-responders in test 2 who had lower
self-reported general health and mental well-being in
test 1. The reliability estimates indicate how well pa-
tients can be distinguished from each other despite the
presence of measurement error, e.g. a lower ICC value
tends to occur in a homogenous study sample [19].
Thus, in this study, the ICC estimates may have been
underestimated due to a homogenous and healthy study
population; whereas the measurement error estimates
were probably less affected.
Conclusion
The WHO-5 Well-being Index showed acceptable
test-retest reliability in a Danish epilepsy outpatient popu-
lation, but the measurement error of the scale was rela-
tively large. Different methods of administration did not
influence the results. Further studies are required to pro-
vide insight into the test-retest reliability and measure-
ment error in different language versions of the WHO-5
Well-being Index and in different patient populations.
Abbreviations
CI: Confidence Interval; ICC: Intraclass correlation coefficients; IQR: Inter
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